Mraz, Amerine & Associates, Inc. Zoetis Inc. Transaction History
Mraz, Amerine & Associates, Inc.
- $521 Million
- Q3 2024
A detailed history of Mraz, Amerine & Associates, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Mraz, Amerine & Associates, Inc. holds 1,756 shares of ZTS stock, worth $296,079. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,756
Previous 1,820
3.52%
Holding current value
$296,079
Previous $315,000
8.89%
% of portfolio
0.07%
Previous 0.07%
Shares
12 transactions
Others Institutions Holding ZTS
# of Institutions
1,952Shares Held
408MCall Options Held
1.02MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA41.2MShares$6.95 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.21 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.33 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.7 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.59 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $78.9B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...